Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Recurrent Head and Neck Squamous Cell Carcinoma”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Testing effectiveness (Phase 2)Looking for participantsNCT07423078
What this trial is testing

Window of Opportunity in Preserving Laryngeal Function Trial

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)Locally Advanced Laryngeal Squamous Cell CarcinomaHypopharyngeal Squamous Cell Carcinoma
Matthew Spector 87
Testing effectiveness (Phase 2)Ended earlyNCT01285635
What this trial is testing

AT-101 in Combination With Docetaxel in Squamous Cell Carcinoma Of The Head and Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck (SCCHN)
University of Michigan Rogel Cancer Center 35
Testing effectiveness (Phase 2)Ended earlyNCT04242173
What this trial is testing

Cemiplimab-rwlc for Unresectable Locally Recurrent and/or Metastatic CSCC

Who this might be right for
Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and Neck
H. Lee Moffitt Cancer Center and Research Institute 3
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07062354
What this trial is testing

Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head &Amp; Neck CancerHead &Amp; Neck Squamous Cell Carcinoma
SWOG Cancer Research Network 50
Testing effectiveness (Phase 2)UnknownNCT00995358
What this trial is testing

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Testing effectiveness (Phase 2)Looking for participantsNCT05136196
What this trial is testing

BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+22 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT01075828
What this trial is testing

Prospective, Post Marketing Surveillance Study On Erbitux® (Cetuximab) in Patients With Locally Advanced or Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck in Korea

Who this might be right for
Head and Neck Cancer
Merck KGaA, Darmstadt, Germany 221
Testing effectiveness (Phase 2)Study completedNCT00103259
What this trial is testing

Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Recurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity+22 more
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Ended earlyNCT01051791
What this trial is testing

Phase II Study of RAD001 Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Julie E. Bauman, MD, MPH 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07128693
What this trial is testing

A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06728618
What this trial is testing

Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma

Who this might be right for
Oral Squamous Cell Carcinoma (OSCC)Oropharyngeal Squamous Cell Carcinoma (SCC)Resectable Oral and Oropharyngeal Squamous Cell Carcinoma+1 more
Shanghai Zhongshan Hospital
Early research (Phase 1)Ended earlyNCT04588038
What this trial is testing

NT-I7 for the Treatment of Recurrent Squamous Cell Carcinoma of Head and Neck Undergoing Surgery

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+3 more
Hyunseok Kang, MD 4
Large-scale testing (Phase 3)Looking for participantsNCT07554456
What this trial is testing

BL-B01D1 in Combination With Tislelizumab ±5-Fluorouracil Versus Platinum-Based Chemotherapy Plus Tislelizumab as First-line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma(PANKU-Esophagus02)

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd. 90
Large-scale testing (Phase 3)Ended earlyNCT00113399
What this trial is testing

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Who this might be right for
Head and Neck Cancer
Radiation Therapy Oncology Group 15
Early research (Phase 1)Study completedNCT01334177
What this trial is testing

TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+38 more
University of Washington 13
Testing effectiveness (Phase 2)Ended earlyNCT00408252
What this trial is testing

Efficacy of SU 011248 in Head And Neck Carcinoma

Who this might be right for
Recurrent DiseaseSquamous Cell Head and Neck CarcinomaPalliative Treatment
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 54
Early research (Phase 1)Looking for participantsNCT06211335
What this trial is testing

Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Locally Recurrent Head and Neck Squamous Cell CarcinomaMetastatic Head and Neck Squamous Cell CarcinomaRefractory Head and Neck Squamous Cell Carcinoma
University of California, Davis 24
Early research (Phase 1)Active Not RecruitingNCT04007744
What this trial is testing

Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage III Gastric Cancer AJCC v8Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8+19 more
Mayo Clinic 36
Testing effectiveness (Phase 2)Ended earlyNCT00093652
What this trial is testing

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Roswell Park Cancer Institute
Large-scale testing (Phase 3)Ended earlyNCT00198328
What this trial is testing

Medpulser Electroporation With Bleomycin Study to Treat Posterior Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head Neck Cancer
Inovio Pharmaceuticals 84
Next Page
150
28